DUBLIN, Nov. 20, 2013 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has completed the restructuring of the U.S. Specialty Brands sales organization, following the completion of the acquisition of Warner Chilcott on October 1, 2013.
In total, Actavis Specialty Brands will have a sales organization comprised of approximately 750 U.S. sales professionals, including sales representatives, district managers, national account managers and associated management, compared to a com...
DUBLIN, Nov. 14, 2013 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone Topical Solution, 30mg/1.5mL. Actavis' ANDA product is a generic version of Eli Lilly and Company's Axiron®, which is an androgen indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
Eli Lilly an...
DUBLIN, Oct. 31, 2013 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Isotretinoin Capsules, 10 mg, 20 mg, 30 mg and 40 mg. Actavis' ANDA product is a generic version of Ranbaxy Inc.'s Absorica®, which is a retinoid indicated for the treatment of severe recalcitrant nodular acne in patients 12 years of age and older.
Cipher Pharmaceuticals, Inc., Ga...
- GAAP Earnings Per Share of $0.49 -
- 61% Increase in Adjusted EBITDA to $489 million -
- Company Updates 2013 Forecast, Provides Preliminary 2014 Outlook -
DUBLIN, Oct. 29, 2013 /PRNewswire/ -- Actavis plc (NYSE: ACT) today reported net revenue increased 57 percent to $2.01 billion for Actavis, Inc.'s third quarter 2013, compared to $1.29 billion in the third quarter 2012. On a non-GAAP basis, diluted earnings per share for the third quarter 2013 were $2.09, compared to $1.35 per di...
Morris Corporate Center III
400 Interpace Parkway
Parsippany, NJ 07054
1 Grand Canal Square, Docklands
Dublin 2, Ireland
Stockholder Information Questions concerning stock ownership
may be directed to:
Stock Transfer Agent
PO Box 43001
Providence RI 02940
Toll Free: 855-807-3171
Local: 781-575-4442 www.computershare.com
Independent Accountants PricewaterhouseCoopers LLP
Orange County, California